‘TRIPS Waiver’ must be agreed now, says MSF
Access needs to be ensured for not just COVID-19 vaccines, but all COVID-19 medical tools, for everyone, everywhere
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Tag
intellectual property
US and India discuss IP-led solutions to global pandemic
The 4th Annual IP Dialogue virtually convenes academic, industry and public-sector IP experts
Ease supply of ingredients for making COVID vaccines to India, others: Macron
He also favoured a proposal by India and South Africa at the World Trade Organisation for a temporary lift on the patents on…
USTR, Piyush Goyal talk about vaccine manufacture, TRIPS waiver
Katherine Tai reaffirmed the commitment of the US to help India battle COVID-19
US backs proposal to waive patents for COVID-19 vaccines
The Biden administration has backed this initiative by India and South Africa at the WTO despite stiff opposition from major…
No more the pharmacy/vaccine maker of the world?
India has risen like a phoenix before, but this time, this resilience comes at too high a price
Who will save the saviours?
Even as vaccine manufacturers, hospitals and governments race against a mutating virus, cybercriminals are exploiting weak links…
Our conception of IP and related rights has room – and a need – to evolve
Patrick Kilbride, Senior Vice President, Global Innovation Policy Center, US Chamber of Commerce explains why he believes that if…
Countries must build consensus around proposal to waive certain IP during COVID-19 pandemic: MSF
All COVID-19 health tools and technologies should be true global public goods, free from the barriers that patents and other…
MSF welcomes EU pharmaceutical strategy but challenges key intellectual property issue
The EC incorrectly justifies this spending as investments in innovation. Instead of proposing a (unitary) SPC system in Europe, a…